Canada Markets closed

Insmed Incorporated (INSM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
20.25+0.68 (+3.47%)
At close: 04:00PM EDT
19.24 -1.01 (-4.99%)
After hours: 07:12PM EDT
Sign in to post a message.
  • Z
    Now you know "the rest of the story"
  • I
    Insmed afternoon ( Tues) PR = Insmed Presents New Data Across Three Pillars at American Thoracic Society 2022 International Conference, (2021 and pre-clinical data already PR, I don't see anything new ) but nice the company is pushing out PRs.
    Poster: "Reduction in Hospitalizations Following Initiation of Amikacin Liposome Inhalation Suspension: A Retrospective Cohort Study of Patients in Real-world Settings"
    Poster: "The Hospitalization Burden Among Potentially Treatment-Refractory Nontuberculous Mycobacterial Lung Disease Patients in Japan"
    Poster: "Pulmonary Exacerbations (PEx) and Hospitalizations in Commercially Insured Patients with Non-Cystic Fibrosis Bronchiectasis (NCFBE) Over 1- and 2-Year Follow-Up Periods"
    Posters: "Treprostinil Exerts Anti-Fibrotic Effects via the Prostanoid Receptor Subtype EP2 in Human Lung Fibroblast"; "Administration of Treprostinil to the Basolateral Surface, but Not the Apical Surface of Human Bronchial Air-Liquid Interface Epithelial Cells Induces Release of Prostaglandin E2"; and "Binding Affinity of Treprostinil to Rat Recombinant Prostanoid Receptors IP and EP2"
  • j
    SEC documents published today on the Insmed, Inc website show insiders who recently were given options sold an amount almost certainly for tax reasons.
  • P
    Some control ,Management and the Institutions
    So it appears upper management got a quarter million dollars in free shares compensation. Institutions then covered their short ( part of) and pumped up those shares 25%+ , and the profit was used to pay their taxes.
    I'll give it to them , they are using this stock as a money laundering operation.
  • Q
    Institutional Holdings now fully reported
    Really not much change in ownership from the previous quarter with a few million shares bought and sold and aprx 9% institutional short position.
    New Positions 33 2,143,688
    Sold Out Positions 19 589,021
    Solid Institutional ownership.
  • I
    P.ress Release May 17, 2022 Insmed To Present at the H.C. Wainwright Annual Global Life Sciences Conference.
    " To Present " vs "a chat" at 7AM.
    From options to pillars to chats, this bio is really getting on my nerves
  • P
    Paul Thompson
    Maybe someone can tell me why I am unable to access the Annual shareholders meeting as promised by the company. Did management address the compassionate care issue? , the Motus plan ? an update on the Brensocatib and arikayce trials ? No they are not saying a word. I've owned biotechs for many years and this is the biggest con I've ever seen, unless you think Institutions who buy an offering can then turn around and short it, because they know a lot more then us. I know , we tanked with the market but down 60% a pharma with revenues and 3 P3 trials?. 100% Institutions that sold some shares bought them back so the 3 months between reporting you cant see who did it. And yes! Congratulations to management on your "compensation' raise.
  • J
    Joe West
    Recent moves by management to take profits is wise because INSM and SPX are headed back down. The SPX today entered a Bear market. The 2020 lows of $14.31 and 2300 are possible.(many see 3750 bottom). History s timeline of the length of the Bear is about 13 months.2020 bear was just days ,it was a covid bear, this one is a historical market teetering on a recession. INSM will not be immune to markets. Have a great weekend
  • t
    In bioteck News that evidently thrilled thecnt Marjorie Taylor Greene, "Pharma Bro" Martin Shkreli who raised the price of an AIDS drug at least 5000% overnight has been released.
  • F
    Fghyujk Sdfghj
    When terry_insm called the low 19.98 or $ 13 in a market crash the spam was as expected.
    Traders do not think we have seen capitulation. I just buy what I can afford GLD and INSM.
    Crash data 1987 S&P down 35% ] 2000 down50% ] 2007 S&P down57% ] 2020 S&P down 35%
    So far the S&P is down 15.7% NBI Biotech is down almost 40% and Insmed is down aprx 55%
    I was going to put up how long it took to regain their previous status but that would be depressing.
    Those holding INSM are averaging down. Those trading are making the most. Institutional numbers due soon may change perception but we know in a market crash all it takes is one of the top 5 holders being forced to sell. Who would take $40? that train has left the station. Have a nice weekend. (
  • r
    Insiders get cheap shares! LEWIS W ($812,532)SHAROKY MELVIN MD ( Bought 20k given 14.5 for $0) Flammer (CMO arikayce post below) all got "incentive shares" ! Congrats.
  • t
    Anyone see the new short interest data shows another 100k shares and the highest short interest since 2018 when INSM share price reached $13.12?
    This is where Insmed Institutions are making money without any risk. Lewis was voted in today with 96% of the votes of Institutions and a Yes vote for more "compensation"
  • P
    There have been many examples of takeovers here in the past where the stock price is cut in half then taken out at the old high. Yesterday Biohaven Pharma is another example.
    Is INSM a $43 takeover? Look at the numbers Institutional holdings revenue etc that fits pretty well. For those scoffing, Remember ;everyone has a price they would sell and only the top 6 Institutions matter anyway.
  • a
    Form 4 s out and plenty of free shares to management .How does the CMO get 21k+shares?? Cant get a P2 test for PAH done . (we "underestimated the difficulty" STOP with the excuses) Others got 14+k .Pauls post is so true. Its a bank for these people. Whats next? another offering? Wouldn't surprise me
  • J
    Joe West
    Discussed again today Terry deleted when he left . Compassionate care use of brensocatib
    An Expanded Access Study to Assess Brensocatib for Participants With Non-Cystic Fibrosis Bronchiectasis - NCT05344508..
    News was released on the eve of April 25 and Terry posted it later that night (4-26)
    Goldman Sachs initiated their Buy and $56 dollar target on April 27.
    We think this issue is important for SH and will wait judgement until we hear what the company has to say although Lewis will be walking a tightrope on how much he can "promote this study" "The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. "
  • r
    The Child taxcredit has helped Moms or + the expanded healthcare that now covers more then 25 million additional Americans or getting us out of Afg.hanis.tan where US kids were still getting killed 20 yrs later or the 1.x Trillion Infrast.ructure signed into Law
  • P
    First half hour accounted for 90% of todays Vol.
    Wake me when we get to the $25 offering more then a year ago.
  • K
    INSM PR ! \ H.C. Wainwright Annual Global Life Sciences Conference. May 24
    LOL ! \ 7 AM \ Do we fly Lewis to Miami? or is this another "virtual extravaganza " \ Does Lewis open up the Fontainebleau? \ Insmed PR as a Presentation (chat) is more nothing from Insmed.\ a useless "chat"\
  • Y
    Coming Soon , a Wainwright Upgrade! after ( This mornings PR ) a Presentation" ( chat)
    May 24th 7 AM. Will this inform as much as the vaporized ASM?!
    sentiment: Yawn
  • J
    Joe West
    Bear market rally's are often sharp quick and gives the short interest a chance to cover.
    imo , I will believe a move up when we move past the offering price of $25
    Note the lower volume for todays move. As a day trade many made $$